| Name | Title | Contact Details |
|---|
“We are a part of the circle of life. It`s as touching and important to be a part of the end of life as it is to be at the beginning. We provide our patients dignity, comfort and quality of life at the end of their journey. Our job is so much more about life than death! Being present during this sacred time is truly and honor, a calling. “ -Jane, LPH Registered Nurse **** Chapters Health System is committed to enhancing the lives of those affected by advancing age or illness. Through our comprehensive system of healthcare choices, we deliver expert care and heartfelt support to guide the community during the aging and end-of-life journey. From hospice and palliative care for adults and children suffering with life-threatening or life-limiting illnesses to in-home and community-based services for frail but independent seniors, Chapters Health offers a wide range of support services along life`s ever-changing landscape. By providing choices, education and guidance, Chapters Health helps enhance the lives of those affected by advancing age or illness. Chapters Health System includes Chapters Health Palliative Care, Chapters Health Pharmacy, Chapters Health Staffing, Good Shepherd Hospice, HPH Home Health, HPH Hospice and LifePath Hospice.
MIDWEST OPTICAL SYSTEMS, INC. is a Palatine, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bon Secours Health System, Inc. based in Marriottsville, Maryland, is a $3.2 billion dollar not-for-profit Catholic health system that owns, manages or joint ventures 18 acute care, 5 long term care, 4 assisted living, 6 retirement communities/senior housing, 14 home care and hospice services, and other facilities, primarily on the East Coast. Bon Secours Health System consists of more than 24,000 caregivers helping people in seven states. Its vision is to be a prophetic Catholic health ministry partnering with communities to create a more humane world, build health and social justice and provide exceptional value for those served.
Founded in 1996, Wellmont Health System is the premier healthcare provider in Northeast Tennessee and Southwest Virginia.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.